OS Therapies Incorporated
OSTX · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$8,883 | -$7,792 | -$6,255 | -$7,420 |
| Dep. & Amort. | $3 | $4 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $268 | $0 | $0 | $0 |
| Change in WC | -$130 | $2,017 | $947 | $575 |
| Other Non-Cash | $1,459 | $2,763 | $1,514 | $2,442 |
| Operating Cash Flow | -$7,282 | -$3,007 | -$3,793 | -$4,403 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$12 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $1 | $231 | $212 |
| Investing Cash Flow | $0 | $1 | $231 | $200 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $1,501 | $3,158 | $3,824 | $2,950 |
| Stock Issued | $5,226 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$31,250 | $0 | $0 | $0 |
| Other Fin. Act. | $37,300 | -$284 | -$172 | $100 |
| Financing Cash Flow | $12,777 | $2,873 | $3,652 | $3,050 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $5,495 | -$132 | $91 | -$1,152 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $39 | $171 | $81 | $1,233 |
| End Cash | $5,534 | $39 | $171 | $81 |
| Free Cash Flow | -$7,282 | -$3,007 | -$3,793 | -$4,415 |